# Safety and Efficacy of Nirsevimab in a Universal Prevention Program of Respiratory Syncytial Virus Bronchiolitis in Newborns and Infants in the First Year of Life in the Valle d’Aosta Region, Italy, in the 2023–2024 Epidemic Season

*PRI Rank #9 · Topics and Trends in Most Cited Neonatal Respiratory Health Research Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/neonatal-respiratory-health-research/2026/rank-9*

| Field | Value |
| --- | --- |
| Rank | #9 |
| 18m citations | 44 |
| Journal | Vaccines |
| Year | 2024 |
| DOI | 10.3390/vaccines12050549 |
| Corresponding authors | Susanna Esposito |
| Institution | Local Health Authority Valle d'Aosta, Italy |

**Ranking page:** [Topics and Trends in Most Cited Neonatal Respiratory Health Research Papers, Class of 2026](https://pri.pepkio.com/top-papers/neonatal-respiratory-health-research/2026)

**Paper link:** [10.3390/vaccines12050549](https://doi.org/10.3390/vaccines12050549)

## Topics

nirsevimab · Respiratory syncytial virus (RSV) · RSV bronchiolitis · Monoclonal antibody · universal prophylaxis · Infants · Infants under 1 year · Valle d'Aosta · 2023–2024 epidemic season · Hospitalization prevention · Passive immunization · RSV prophylaxis · prophylaxis adherence · real-world effectiveness

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Neonatal Respiratory Health Research Papers, Class of 2026. https://pri.pepkio.com/top-papers/neonatal-respiratory-health-research/2026. Accessed 2026-07-22.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```